Common painkiller may help reverse Alzheimer’s-related memory loss
By
Aug 15, 2016
An anti-inflammatory drug commonly used to treat pain associated from menstrual cramps may be able to reverse memory loss linked to Alzheimer’s disease, new research shows.
Change Healthcare touts attachment capability
By
Kimberly Marselas
Jan 21, 2020
Change Healthcare has beefed up its claim attachments solution, creating the first nationwide solution enabling providers to submit documents and data electronically to all payers in both the medical and...
Omnicare settles kickback, FCA cases for $31 million
By
Jul 06, 2017
Long-term care pharmacy giant Omnicare agreed to pay a total of $31 million in May to settle allegations it submitted false claims and accepted kickbacks to promote certain drugs.
Chicago’s massive suit over OxyContin alleges painkiller drug companies have misled prescribers and patients, leaving many woefully addicted and the city with enormous costs for treating them.
CMS issues notice of sanctions to Medicare Advantage insurer
May 19, 2010
The Centers for Medicare & Medicaid Services this week informed Medicare Advantage insurer Quality Health Plans of its intent to impose intermediate sanctions and a civil monetary penalty (CMP) on the...
Genes influence likelihood of hip fractures among older adults
By
Haymarket Media
Sep 30, 2005
Heredity plays a role in determining whether people under 69 will suffer a first hip fracture, a new study says.
Clinical briefs for Wednesday, July 28
By
Alicia Lasek
Jul 28, 2021
Vaccine reporting requirements overwhelm providers during COVID-19 outbreaks … Delta variant’s spread prompts CDC to re-up indoor mask-wearing recommendation … VA becomes first federal department...
Dementia residents among most antibiotic-resistant, study reveals
By
John Hall
Apr 30, 2015
Because they are prone to rehospitalization, typically demand intensive hands-on care and are heavy users of antibiotics, advanced dementia residents in nursing homes commonly harbor dangerous strains...
Buzz kill: Marijuana is not effective at treating Alzheimer’s, researchers find
Feb 09, 2010
A Canadian study has called into question marijuana’s effectiveness as a potential treatment for Alzheimer’s disease.
Omnicare extends PharMerica buy offer
By
John O'Connor
Jan 03, 2012
Pharmacy giant Omnicare announced that it was extending to Jan. 20 its offer to purchase all outstanding shares of rival PharMerica for $15 per share. The original offer had been scheduled to expire in...